Filter posts

Licensing of Academic Patents Has Contributed Up to $1.3 Trillion to US Economy

The licensing of university research has made a significant contribution to US gross domestic product …

State Leaders Discuss Bioscience Economic Development

This week BIO released Bioscience Innovation in the States: Legislation and Job Creation through Public-Private …

New BIO White Paper Outlines Policies to Better Combat Antimicrobial Resistance

In recent years, the global community has directed a high level of political attention to …

Commonsense Solutions to Lower Drug Costs

With a national debate underway over drug prices, people are looking for ways to help …

BIO Statement on SCOTUS Biosimilar Products Ruling

On Monday the United States Supreme Court issued a decision in Sandoz, Inc. v. Amgen, …

A Cheat Sheet for Today’s Drug Price Hearing

The debate over drug pricing is heating up in various states across the country. But …

#BIO2017: What's Happening in the World of IP?

Who’s ready to hit the beach? Wait, did I say beach? I meant the San …

BIO Reacts to Supreme Court opinion in Impression Products, Inc. v. Lexmark International, Inc.

On Tuesday, May 30, 2017, the U.S. Supreme Court issued an opinion in  Impression Products, Inc. …

USTR’s Report Targets Trade Barriers to Biotech

The Office of the United States Trade Representative’s (USTR) annual Special 301 Report identifies trade …

IRS Issues Guidance on Start-up R&D Credit

At the end of March, the IRS issued interim guidance explaining how eligible small businesses …